Protracted elevation in intracellular calcium caused by the activation of the N-methyl-D-aspartate receptor is the main cause of glutamate excitotoxic injury in stroke. However, upon excitotoxic injury, despite the presence of calcium entry antagonists, calcium unexpectedly continues to enter the neuron, causing extended neuronal depolarization and culminating in neuronal death. This phenomenon is known as the calcium paradox of neuronal death in stroke, and it represents a major problem in developing effective therapies for the treatment of stroke. To investigate this calcium paradox and to determine the source of this unexpected calcium entry after neuronal injury, we evaluated whether glutamate excitotoxicity activates an injury-induced calcium-permeable channel responsible for conducting a calcium current that underlies neuronal death. We used a combination of whole-cell and single-channel patchclamp recordings, fluorescent calcium imaging, and neuronal cell death assays in a well characterized primary hippocampal neuronal culture model of glutamate excitotoxicity/stroke. Here, we report activation of a novel calcium-permeable channel upon excitotoxic glutamate injury that carries calcium current even in the presence of calcium entry inhibitors. Blocking this injury-induced calcium-permeable channel for a significant time period after the initial injury is still effective in preventing calcium entry, extended neuronal depolarization, and delayed neuronal death, thereby accounting for the calcium paradox. This injury-induced calcium-permeable channel represents a major source for the initial calcium entry following stroke, and it offers a new target for extending the therapeutic window for preventing neuronal death after the initial excitotoxic (stroke) injury.
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Stroke is a leading cause of disability and death, yet its successful treatment is limited (Bonita et al., 2004) . Glutamate is the predominant excitatory neurotransmitter in the mammalian central nervous system, and it is required for neural development, synaptogenesis, and alterations in synaptic plasticity (Dingledine et al., 1999) . In excessive quantities, glutamate is thought to cause the neuronal damage observed following stroke, epilepsy, and traumatic brain injury (Siesjö and Bengtsson, 1989; Delorenzo et al., 2005) . Protracted elevation in intracellular calcium [Ca 2ϩ ] i caused by the activation of the N-methyl-D-aspartate (NMDA) subtype of glutamate receptors is the main cause of excitotoxic injury in stroke (Choi, 1995; Lipton, 1999) . Excitotoxic glutamate exposure causes two major, long-lasting changes in neuronal physiology. Our laboratory and others have demonstrated that glutamate exposure results in a prolonged dis-turbance in neuronal Ca 2ϩ homeostasis, producing protracted elevations in [Ca 2ϩ ] i that persist following the removal of glutamate (Glaum et al., 1990; Michaels and Rothman, 1990; Dubinsky, 1993; Choi, 1995; Limbrick et al., 1995 Limbrick et al., , 2001 Limbrick et al., , 2003 . In addition, excitotoxic glutamate exposure causes extended neuronal depolarization (END), a condition that lasts for several hours after glutamate removal (Sombati et al., 1991; Coulter et al., 1992; Limbrick et al., 2003) . Both the protracted [Ca 2ϩ ] i elevations and END follow similar time courses, require NMDA receptor activation and an increase in [Ca 2ϩ ] i for induction, and correlate with excitotoxic neuronal cell death (Sombati et al., 1991; Coulter et al., 1992; Limbrick et al., 2003) .
Conventional Ca 2ϩ entry antagonists prevent neuronal death and END when administered before and during the injury phase of glutamate excitotoxicity (Coulter et al., 1992; Limbrick et al., 2001 ), but after excitotoxic insult has occurred, these Ca 2ϩ entry antagonists are no longer effective in blocking the Ca 2ϩ entry and in reducing the elevated [Ca 2ϩ ] i (the Ca 2ϩ plateau). Thus, traditional Ca 2ϩ entry antagonists do not prevent END (Limbrick et al., 2003) , block neuronal death (Ikonomidou and Turski, 2002) , or improve the outcome after the excitotoxic injury in stroke (Horn and Limburg, 2000) . These observations have lead to the Ca 2ϩ paradox of neuronal death in stroke, and they refer to the unexpected finding that conventional Ca 2ϩ entry antagonists do not prevent Ca 2ϩ entry or END after glutamate excitotoxicity (Lee et al., 1999; Horn and Limburg, 2001; Ikonomidou and Turski, 2002) . Explaining the cause of the Ca 2ϩ paradox of neuronal death in stroke is one of the important problems in neuroscience research, and it underlies the failure of many of the previous clinical trials for potential neuroprotective agents in stroke and brain injury (Lee et al., 1999; Horn and Limburg, 2001; Ikonomidou and Turski, 2002; Wahlgren and Ahmed, 2004) . Our previous attempts at elucidating the Ca 2ϩ paradox identified that an influx of extracellular Ca 2ϩ was underlying the genesis of END. However, that study could not identify the source or nature of this postinjury Ca 2ϩ entry (Limbrick et al., 2003) . Therefore, it is important to explain this Ca 2ϩ paradox and to understand the continued Ca 2ϩ entry after injury despite the use of known Ca 2ϩ entry inhibitors to develop novel and effective stroke and brain injury therapeutic agents.
In this study, using a well characterized in vitro hippocampal neuronal culture model of glutamate excitotoxicity/ stroke, we investigated the cause of the Ca 2ϩ entry after injury that is resistant to known Ca 2ϩ entry inhibitors. Experiments were directed at evaluating the development of an injury induced Ca 2ϩ current that underlies END and cell death that is not blocked by conventional Ca 2ϩ entry inhibitors. Studies were also directed at demonstrating that this novel injury-induced Ca 2ϩ current accounts for the Ca 2ϩ paradox, because traditional Ca 2ϩ entry inhibitors, including blockers for L-, N-, P/Q-, and T-type Ca 2ϩ channels, NMDA/ AMPA/KA channels, stretch-activated channels, and other injury-induced cation channels, such as the TRPM-7 and acid-sensing channels, did not block this Ca 2ϩ entry. Furthermore, our results also demonstrate that there is a therapeutic window of opportunity of at least 1 h to block this current, decrease the elevated [Ca 2ϩ ] i , reverse END, and prevent neuronal death. The development of a novel injuryinduced Ca 2ϩ -permeable channel provides a molecular basis for the postinjury Ca 2ϩ entry current responsible for producing END (Limbrick et al., 2003) , and it explains why many of the therapeutic trials using conventional strategies to inhibit Ca 2ϩ entry have not been effective in treating stroke. Activation of this injury-induced Ca 2ϩ -permeable channel represents an early step in the cascade leading to excitotoxic neuronal death, and it offers potential insight into developing novel therapeutic interventions to prevent brain injury from stroke.
Materials and Methods
Materials. All the reagents were purchased from Sigma-Aldrich (St. Louis, MO), unless otherwise noted. ␣-Methyl-4-carboxyphenyl glycine (mCPG), SKF-96365, and tetrodotoxin (TTX) were obtained from Tocris Cookson Inc. (Ballwin, MO), Calbiochem (San Diego, CA), and Alomone Labs (Jerusalem, Israel), respectively. 4,4Ј-Diisothiocyanatostilbene-2,2Ј-disulfonic acid (DIDS), N -nitro-L-arginine methyl ester (L-NAME), and amiloride hydrochloride (AMILO) were purchased from Sigma-Aldrich. Minimal essential medium, L-glutamine, trypsin, penicillin-streptomycin, fetal bovine serum, and horse serum used in the tissue culture preparation were obtained from Invitrogen (Carlsbad, CA).
Hippocampal Neuronal Cultures. All animal use procedures were in strict accordance with the National Institute of Health Guide for the Care and Use of Laboratory Animals and approved by Virginia Commonwealth University's Institutional Animal Care and Use Committee. Cultured hippocampal neurons were prepared as described previously from 2-day postnatal Sprague-Dawley rats (Harlan, Frederick, MD) with slight modifications (Sombati et al., 1991; Coulter et al., 1992; Limbrick et al., 2001) . Cultures were fed thrice weekly with neuronal feed, maintained at 37°C in a 5% CO 2 , 95% air atmosphere, and used after 14 days in vitro.
Electrophysiology. Whole-cell patch-clamp analyses were performed as described using an Axopatch 200A amplifier or an Axopatch 1D amplifier (Molecular Devices, Sunnyvale, CA) in voltageclamp mode (Hamill et al., 1981; Coulter et al., 1992) . Membrane potential was sequentially stepped from Ϫ90 to ϩ60 mV from a steady holding potential of Ϫ60 mV. Voltage steps were 50 ms in duration and applied at a frequency of 0.2 Hz. Current responses were sampled at 20 kHz and low-pass filtered at 1 kHz using a four-pole Bessel filter (Frequency Devices, Haverhill, MA). The recording solution contained 145 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 10 mM glucose, 2 mM CaCl 2 , and 1 mM MgCl 2 , pH 7.3 (290 Ϯ 10 mOsM). The pipette solution contained 140 mM K ϩ gluconate, 10 mM HEPES, 1.1 mM EGTA, and 1 mM MgCl 2 , pH 7.2 (290 Ϯ 10 mOsM). Depending upon the experiments, various inhibitors were included in the recording solution. In establishing the whole-cell configuration, gigaseal formation was verified, pipette capacitance was canceled, and gentle suction was applied. Cells that required Ͼ3 applications of suction for whole-cell access were discarded. Once whole-cell access was established, whole cell capacitance was canceled. Series resistance was generally 4 to 9 M⍀, but it was reduced by 75 to 80% using the compensation circuit of the amplifier. Series resistance error was generally between 3 and 5 mV (but always Ͻ9 mV).
Cell-attached single-channel recordings were performed as described previously (Hamill et al., 1981) . Fire-polished Slygard (Dow Corning, Midland, MI)-coated borosilicate glass pipettes had a resistance of 7 to 10 m⍀ when filled with recording solution containing 145 mM NaCl, 2.5 mM KCl, 10 mM HEPES, 10 mM glucose, 2 mM CaCl 2 , and 1 mM MgCl 2 , pH 7.3 (290 Ϯ 10 mOsM). Depending upon the experiment, various inhibitors were included in the pipette solution. Neurons were bath perfused with a "high-K ϩ " solution in which the extracellular KCl concentration was raised from 2.5 to 40 mM to clamp the resting membrane potential near 0 mV. The patch was voltage-clamped at various voltages by applying a voltage of opposite sign to the patch pipette, and the recording was started. Current amplification was accomplished with an Axopatch 200A amplifier and recorded on a VHS tape via a Neurocorder (Neurodata, NY) using pClamp9 via Digidata 1322A (Molecular Devices). Data were sampled at 10 kHz and filtered at 2 kHz.
Excitotoxic Glutamate Exposure. Excitotoxic injury was induced as described previously (Choi et al., 1987; Michaels and Rothman, 1990; Sombati et al., 1991; Coulter et al., 1992; Dubinsky, 1993; Limbrick et al., 1995) . Bath application of glutamate was performed by gravity-feed perfusion at a rate of 1 ml/min, and solution changes were controlled through a six-valve perfusion system (Warner Instruments, Hamden, CT). Glutamate (500 M) was dissolved in recording solution and applied with 10 M glycine for 10 min. Glutamate washout was performed with control recording solution (2 mM CaCl 2 ) or Ca 2ϩ -free recording solution (0 mM CaCl 2 ; omitting CaCl 2 but contained no Ca 2ϩ chelator), or high-Ca 2ϩ recording solution (10 mM CaCl 2 ; equimolar replacement of NaCl), or Na ϩ -free recording solution [equimolar substitution of N-methyl-D-glucamine (NMDG) chloride for NaCl].
Calcium Microfluorometry. Fura-2 acetoxymethyl ester was loaded in the neurons and then transferred to a heated stage (37°C) of an Olympus IX-70 inverted microscope (Olympus, Tokyo, Japan) coupled to an ultrahigh-speed fluorescence imaging system (Olympus/PerkinElmer Life and Analytical Sciences, Boston, MA) (Dubinsky, 1993; Limbrick et al., 1995) . Ratio images were acquired by using alternating excitation wavelengths (340/380 nm) with a filter wheel (Sutter Instrument Company, Novato, CA) and Fura filter cube at 510/540-nm emissions with a dichroic mirror at 400 nm. Image pairs were captured and digitized every 15s, and the images at each wavelength were averaged over four frames and corrected for background fluorescence by imaging a nonindicator-loaded field.
Cell Death Assay. Neuronal death was characterized using the Vybrant apoptosis assay kit 3 (Invitrogen) (Raza et al., 2001) . Cells were treated with fluorescein isothiocyanate Annexin-V (5 l/100 l of total volume) and 1 l of 100 g/ml propidium iodide (PI) solution. After 15 min, 400 l of 1ϫ Annexin binding buffer was added, and cells were visualized. Fraction of neuronal death was calculated as fraction dead ϭ (dead treat Ϫ dead control )/dead glutamate .
Data Analysis. Averaging the final 17 ms of each step to minimize any effect of 60-Hz noise generated steady-state current-voltage (I-V) relationships. Permeability ratios were calculated using the Goldman-Hodgkin-Katz voltage equation. Statistical differences in the magnitude of current responses or END potentials or cell death were tested using a one-way analysis of variance followed by post hoc Tukey's test. Single-channel analyses were accomplished using Clampfit 9 (Molecular Devices). Statistical tests were run using SigmaStat 2.0, and graphs were generated with SigmaPlot 8.0 (both from SPSS Inc., Chicago, IL).
Results

Excitotoxic Glutamate Injury Produces a Persistent Inward Excitotoxic Injury Current (I EIC ).
To investigate the molecular basis of END, whole-cell recordings were conducted on control and glutamate-injured neurons in the presence of a mixture of Ca 2ϩ entry inhibitors that were demonstrated to inhibit voltage-gated Ca 2ϩ channels (5 M nifedipine), NMDA channel (10 M MK-801), AMPA/KA channels (10 M CNQX), the TRP channel family, and stretch-activated ion channels (10 M GdCl 3 ) (Sattler et al., 1998; Aarts et al., 2003) . Recordings in the presence this Ca 2ϩ entry inhibitor cocktail have been shown by our laboratory and others (Sattler et al., 1998; Aarts et al., 2003) to inhibit the standard mechanisms of Ca 2ϩ entry and to provide the ability to investigate the presence or absence of Ca 2ϩ entry following excitotoxic injury.
Control neurons exhibited a membrane potential of Ϫ56.7 Ϯ 1.3 mV and mean input resistance of 240.7 Ϯ 32.5 M⍀ (n ϭ 10; Table 1 ). Whole-cell voltage-clamp recordings from control neurons in the presence of cocktail of Ca 2ϩ entry inhibitors showed no steady-state inward currents (Fig. 1A) . Outward currents consistent with activation of voltage-dependent K ϩ channels were observed in control neurons at voltages positive to Ϫ40 mV, and they were sensitive to K ϩ channel blockers (4-aminopyridine and charybdotoxin). In contrast, excitotoxic glutamate injured neurons in the presence of Ca 2ϩ entry inhibitors mixture manifested END (Sombati et al., 1991; Coulter et al., 1992) and exhibited a membrane potential of Ϫ14.0 Ϯ 1.6 mV and an input resistance of 26.6 Ϯ 3.4 M⍀ that were statistically different from control neurons ( p Ͻ 0.001 for both; Table 1 ). Neurons in END revealed a persistent I EIC (Fig. 1A) . We contend that this persistent inward current represents the basis of the Ca 2ϩ paradox. The peak inward current for the END conditions in the presence of Ca 2ϩ entry inhibitors was Ϫ3934.6 Ϯ 635.5 pA (n ϭ 12). Steady-state outward currents in excitotoxic glutamate-injured neurons were identical in magnitude to those observed in control neurons. The net I-V relationships (Aarts et al., 2003) for glutamate-injured neurons (total EIC minus control; Fig. 1B ) were studied in the remaining experiments. This net inward current had a reversal potential (E rev ) of approximately ϩ40 mV.
Cell-attached single-channel recordings from glutamateinjured neurons demonstrated distinct openings and closings of an ion channel that existed in the presence of Ca 2ϩ entry inhibitors and corresponded to the appearance of I EIC during END (Fig. 1C) . This channel exhibited an essentially linear I-V relationship with a unitary conductance of 49.5 Ϯ 5.2 pS ( Fig. 1D ) (n ϭ 7). Conversely, control neurons demonstrated no channel activity in the presence of Ca 2ϩ entry inhibitors. We recently showed that END could be reversed by application of 100 M GdCl 3 or removal of [Ca 2ϩ ] e after glutamate excitotoxicity (Limbrick et al., 2003) . To investigate whether activation of I EIC and the observed channel were responsible for mediating END, we recorded whole-cell and single-channel currents under these conditions (Limbrick et al., 2003) . Application of 100 M Gd 3ϩ or removal of [Ca 2ϩ ] e in the postglutamate END period abolished the inward current and restored the I-V profile identical to that of a control neuron (Fig. 1, E and F) . In addition, Gd 3ϩ -treated neurons (n ϭ 14) and neurons recorded in absence of [Ca 2ϩ ] e (n ϭ 11) had a mean membrane potential of Ϫ52.4 Ϯ 3.9 and Ϫ49.6 Ϯ 3.4 mV, respectively. The mean input resistance for these two Fig. 2A) , they did not affect the magnitude of I EIC (Fig.  2B ), and they had no effect on channel activity (Fig. 2C) . In addition, removal of Na ϩ did not affect the membrane potential (Ϫ9.4 Ϯ 2.0 mV) or input resistance (38.3 Ϯ 5.2 M⍀), compared with END neurons ( p ϭ 0.101 and 0.093, respectively; n ϭ 16; Table 1 ). These results indicate that Na ϩ influx did not significantly contribute to I EIC .
Removing [Ca 2ϩ ] e following glutamate excitotoxicity completely reversed END ( Fig. 2A) , abolished I EIC (Fig. 2B) , and also abolished single-channel events (Fig. 2C) . Neurons subjected to Ca 2ϩ -free conditions after excitotoxic injury exhibited a mean membrane potential of Ϫ49.6 Ϯ 3.4 mV and an input resistance of 257.4 Ϯ 39.7 M⍀ that were not significantly different from values for control neurons ( p ϭ 0.075 and 0.745, respectively; n ϭ 11; Table 1 ). Permeability ratios calculated from the Goldman-Hodgkin-Katz equation (Hille, 2001), using the steady-state E rev , indicated that I EIC is mediated by a highly selective Ca 2ϩ conductance that is 50 times more permeable to Ca 2ϩ than Na ϩ (P Ca :P Na ϭ 12.5: 0.25).
To further establish that Ca 2ϩ influx was responsible for END and that it was the major ion permeating the I EIC channel, we measured [Ca 2ϩ ] i using Fura-2 imaging. Substituting NaCl with NMDG had no effect on [Ca 2ϩ ] i . Conversely, removing [Ca 2ϩ ] e reversed the elevated [Ca 2ϩ ] i observed after glutamate excitotoxicity (Fig. 2D) .
The Ca 2ϩ dependence of I EIC was then evaluated by investigating the effects of variable [Ca 2ϩ ] e on magnitude of I EIC . The net peak inward currents reduced from Ϫ3932.3 Ϯ 635.5 to Ϫ1119.7 Ϯ 327.4 pA at Ϫ90 mV during 2 and 0.5 mM [Ca 2ϩ ] e (Fig. 2E) , and it also caused a significant shift in the net E rev from ϩ40.5 Ϯ 2.2 to Ϫ20.6 Ϯ 2.0 mV, respectively. This value agreed with the theoretical E rev value of approximately Ϫ22 mV determined by the Nernst equation for 0.5 mM [Ca 2ϩ ] e , and it resulted in the predicted linear relationship of E rev versus log 10 [Ca 2ϩ ] e (Fig. 2F) . The membrane potential for neurons in 0.5 mM CaCl 2 was Ϫ25.9 Ϯ 4.6 mV, and the input resistance was 59.1 Ϯ 6.9 M⍀. These values represent significant changes from those measured in 2 mM CaCl 2 for END ( p ϭ 0.013 and Ͻ 0.001, respectively; n ϭ 9; Table 1 ).
Conversely, increasing [Ca 2ϩ ] e from 2 to 10 mM resulted in an increased net peak inward current of Ϫ5590.8 Ϯ 457.8 pA (Fig. 2E) , and it resulted in a membrane potential of Ϫ1.5 Ϯ 2.4 mV and an input resistance of 22.9 Ϯ 1.7 M⍀. Increasing [Ca 2ϩ ] e to 10 mM caused a shift in the net E rev from ϩ40.5 Ϯ to Ϫ20 mV. Activation of voltage-gated Ca 2ϩ channels (VGCCs) is expected to occur at these potentials. Thus, the observed injury-mediated channel activity could be due to the activation of the voltage-gated Ca 2ϩ channels. To investigate contribution of VGCCs to END, a combination of effective concentrations of L-type VGCC antagonist (5 M nifedipine), N-type VGCC antagonist (1 M ⍀-conotoxin GVIA), P/Q-type VGCC antagonist (100 nM ⍀-conotoxin MVIIC), or T-type VGCC antagonist (1 mM ethosuximide), along with other components of Ca 2ϩ entry inhibitor mixture (such as MK-801 and CNQX), was used to wash out glutamate. Because alterations in VGCC gating could also occur during or after excitotoxic glutamate exposure, we included 200 M CoCl 2 in the inhibitor combination. This combination had no effect on END membrane potentials, suggesting that the VGCCs are not mediating the injury-induced ion channel activity (Fig.  3A) . Most of the cation channels, including the stretch-activated channels and other Ca 2ϩ channels are completely or maximally blocked at GdCl 3 concentrations of 10 M (Caldwell et al., 1998). However, this concentration did not inhibit END or decrease I EIC or single-channel activity after glutamate excitotoxicity. Thus, although use of 10 M GdCl 3 inhibited these other channels under our conditions, it had no effect on END. In fact, END and related physiological processes were abolished only when the Gd 3ϩ concentration was raised to 100 M. This is a very large difference in concentration, and it provides a major distinction. This dose-dependent effect of Gd 3ϩ clearly differentiates the Ca 2ϩ channel observed in our study from the traditional GdCl 3 -sensitive Ca 2ϩ channels previously identified. In addition, voltagegated Ca 2ϩ channels undergo inactivation rapidly after the onset of depolarization. But, we observed a persistent channel activity for a prolonged period in the depolarized END phase. Moreover, VGCCs are characterized by low singlechannel conductance. Taken together, we can conclude that VGCCs are not the mediators of the glutamate injury induced Ca 2ϩ -permeable channel. Given the high Ca 2ϩ permeability of this channel and a requirement of NMDA for channel activation, one probable candidate is the NMDA receptor-gated channel. We used NMDA-receptor antagonists MK-801 (10 M) and APV (50 M) either alone or in combination. MK-801 is a voltagedependent blocker of NMDA receptor ion channel. Thus, its ability to block is limited under depolarized (END) condition. APV is a competitive antagonist, and its ability to block NMDA-receptor depends upon the period of glutamate exposure. Our observations that both the competitive (APV) and noncompetitive (MK-801) pharmacological inhibitors to NMDA channel do not block the postglutamate injury-induced channel activity ( Fig. 1 ; experiments were performed in the presence of Ca 2ϩ entry inhibitor mixture that contained MK-801) or END potentials (Fig. 3A) provide strong evidence that NMDA receptor does not mediate the injuryinduced current. Likewise, the inability of AMPA/KA receptor antagonists (10 M CNQX, 10 M NBQX) or the metabotropic glutamate receptor antagonist (250 M mCPG) used to block the injury-induced channel activity, suggests that other glutamate receptor subtypes do not represent the molecular basis for excitotoxic glutamate-activated channel (Fig. 3A) .
The bivalent metal cation zinc (Zn 2ϩ ) is known to regulate a number of ligand-gated, voltage-gated, and nonselective cation channels, several of which gate Ca 2ϩ entry into the neurons (Christine and Choi, 1990; Chen et al., 1997) . In particular, Zn 2ϩ blocks NMDA and AMPA receptors and most types of VGCCs. However, Zn 2ϩ at a lower 5 M concentration, a concentration that was also greater than the dissociation constant of Zn 2ϩ at the NMDA receptor Zn 2ϩ site (Christine and Choi, 1990) , had no effect on the postglutamate membrane potential (Fig. 3A) . Conversely, inclusion of 500 M ZnCl 2 following removal of glutamate allowed a rapid and complete repolarization to resting membrane potential (Fig. 3B) . Thus, the ability of ZnCl 2 to reverse END was independent of its effects on NMDA receptors.
Other mechanisms of ionic entry were also tested. Inhibiting the forward and reverse mode of Na ϩ /Ca 2ϩ exchanger (50 M bepridil or [Na ϩ ] o removal), chloride channels (100 M DIDS), and stretch receptors channels (10 M GdCl 3 ) also had no effect on diminishing the END potentials after glutamate excitotoxicity (Fig. 3A) . In addition, the strict ionic selectivity, the differential permeability of I EIC , and the fact that changes in [Ca 2ϩ ] i could be measured throughout our experiments demonstrated that I EIC was not the result of a nonspecific ion leak or membrane disruption following glutamate excitotoxicity.
Studies were also done to evaluate the contribution of internal Ca 2ϩ stores that are known to play a major role in [Ca 2ϩ ] homeostasis (Duchen, 2000) . Blocking store-operated Ca 2ϩ channels (10 M SKF-96365), ryanodine receptors (20 M dantrolene), or inositol trisphosphate receptors (2 mg/ml heparin) or intracellular Ca 2ϩ release inhibitor (1 M thapsigargin) (data not shown) had no effect on reducing END. Compensating for mitochondrial injury by addition of an ATP-regenerating system (4 mM ATP and 22 mM phosphocreatine) or by inhibiting mitochondrial Ca 2ϩ release (10 M rhodamine; data not shown) also had no effect on reducing END (Fig. 3A) . Indeed, mitochondria maintain their resting level for Ca 2ϩ for about 45 min after glutamate excitotoxicity,
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even in the face of rising cytosolic Ca 2ϩ levels (Bano et al., 2005) . Moreover, mitochondrial respiration is retained for a relatively long time in cerebellar neurons undergoing excitotoxicity (Jekabsons and Nicholls, 2004) , and the final mitochondrial Ca 2ϩ deregulation and the permeability transition were downstream rather than upstream of the secondary Ca 2ϩ overload following glutamate excitotoxicity (Bano et al., 2005) . Although intracellular Ca 2ϩ stores and other cation conductances may play role in ischemia-induced [Ca 2ϩ ] i accumulation, our results demonstrate that I EIC is responsible for majority of the early Ca 2ϩ influx after glutamate excitotoxicity.
Neuroprotection with Gadolinium: Evidence That I EIC Accounts for the Ca 2؉ Paradox. To test whether activation of I EIC could explain the Ca 2ϩ paradox, we investigated whether blocking this channel could prevent neuronal death after glutamate excitotoxicity. Treatment with 100 M Gd 3ϩ produced a significant reduction in the number of Annexin-positive cells (Figs. 3C and 4) , and it also conferred neuroprotection when administered 1 h after excitotoxic injury (Fig. 3D) . Furthermore, with Gd 3ϩ intervention, up to 50% neuroprotection was observed even out to 2 h after glutamate excitotoxicity (Fig. 3D) .
It has been suggested that activation of neuronal NOS via Ca 2ϩ coming specifically from NMDA receptors plays a role in neuronal cell death. This observation is based on the findings that blocking formation of NO using NOS inhibitors attenuates glutamate-induced neuronal death (Yamauchi et al., 1998) . However, it has been shown that this effect is concentration-and time-dependent (Vigé et al., 1993) . Thus, addition of 100 M N -nitro-L-arginine to the medium either 5 min before and during 500 M L-glutamate exposure for 5 min decreased the amino acid-induced neurotoxicity only by 20%. However, when added 5 min before L-glutamate and kept in contact with neurons for the following 24 h after glutamate removal, 100 M N -nitro-L-arginine antagonized the glutamate-induced neurotoxicity by more than 70% (Vigé et al., 1993) . Several research groups have reported that inhibition of NOS following a 5-to 10-min exposure to 300 to 500 M NMDA did not attenuate neuronal death in primary along with ⍀-conotoxin and ethosuximide), mCPG, TTX, bepridil (BEP), DIDS, SKF-96365, ATP, L-NAME, AMILO, 10 Gd 3ϩ , and 5 Zn 2ϩ (n ϭ 6). Treatment with these agents after glutamate excitotoxicity did not abolish END. B, treatment after glutamate injury with 0 Ca 2ϩ , 100 Gd 3ϩ , and 500 Zn 2ϩ but not 0 Na ϩ (n ϭ 5) inhibited END. C, treatment with 100 M Gd 3ϩ was neuroprotective and prevented neuronal cell death. Conversely, inhibition of TRPM-7 (L-NAME and 10 M Gd 3ϩ ) or ASICs (AMILO) had no effect on fraction of dead cell count. D and E, blockade of the I EIC -Ca 2ϩ -permeable channel at different times after glutamate excitotoxicity demonstrates an the extension of the therapeutic window for preventing cell death and the postinjury [Ca 2ϩ ] i plateau. Glutamate-injured neurons were treated with 100 M Gd 3ϩ (D) or 0-Ca 2ϩ solutions (E) starting at 0 h and up to 4 h after glutamate excitotoxicity. The percentage of neurons undergoing cell death or returning to basal [Ca 2ϩ ] i ratios was measured (n ϭ 6). Data are expressed as mean Ϯ S.E.M. For A and B, asterisks denote differences from control and from glutamate (GLU) for C, D, and E ‫,ء(‬ p Ͻ 0.05). Color scheme: black, control; white, END/glutamate; and gray, inhibitors.
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at ASPET Journals on July 8, 2017 jpet.aspetjournals.org cortical cultures from rat and mouse (e.g., Hewett et al., 1993) . These results from several prominent groups in the neuronal death field clearly demonstrate that NOS inhibition does not attenuate neuronal cell death when the inhibition is administered immediately after a neurotoxic insult. However, pretreatment with various NOS inhibitors can be successful in reducing excitatory amino acid neurotoxicity (e.g., Yamauchi et al., 1998) . In our hands, post-treatment with L-NAME was not effective in blocking neuronal cell death. In addition, we found that when L-NAME was given during and after glutamate insult, only a small but statistically insignificant decrease in neuronal cell death was observed (Fig. 3C) . This is consistent with what is reported in the literature. NOS inhibition only significantly protects neurons when it is inhibited before the injury with glutamate injury.
Fura-2-imaging experiments demonstrated that injured neurons restored excitotoxic glutamate induced elevated [Ca 2ϩ ] i to basal levels for up to 1 h after removal of [Ca 2ϩ ] e (Figs. 3E and 4) . However, beyond this time point, the percentage of neurons that could restore basal [Ca 2ϩ ] i levels started to decrease despite absence of [Ca 2ϩ ] e . These results demonstrate that there is a window of opportunity for neuroprotection of up to 1 h after glutamate excitotoxicity, during which it is possible to reverse the increased [Ca 2ϩ ] i while the I EIC channel is the major source of elevated [Ca 2ϩ ] i . In addition, as shown in Fig. 1A , injured neurons revealed I EIC despite the presence of Ca 2ϩ entry inhibitors. Thus, these data provide an explanation for the Ca 2ϩ paradox by demonstrating that blocking I EIC -Ca 2ϩ -permeable channel was able to prevent Ca 2ϩ entry and inhibitor-resistant Ca 2ϩ entry and reverse END, and inhibit cell death.
Comparison of I EIC to Other Injury-Induced Cation Currents. It is important to compare I EIC to other nonselective cation currents that have been observed in association with different types of neuronal injury. Recently, TRPM-7 channels were shown to carry an anoxia-induced cation current (I OGD ) in cortical neurons (Aarts et al., 2003) . Two hours of anoxia induced I OGD , which was inhibited by 300 M L-NAME or 10 M GdCl 3 and increased in magnitude upon [Ca 2ϩ ] e removal (Aarts et al., 2003) . In contrast, induction of I EIC was rapid, and treatments with L-NAME or 10 M GdCl 3 during and after glutamate excitotoxicity failed to reverse END (Fig. 3A) , inhibit Ca 2ϩ influx (data not shown), or prevent neuronal death (Fig. 3C) . Moreover, I EIC decreased in magnitude upon [Ca 2ϩ ] e removal. Thus, based on the kinetic characteristics and pharmacological comparisons, it seems that TRPM-7 channels are not responsible for mediating I EIC .
Acidosis from ischemia induces the activation of amiloridesensitive high Na ϩ -low Ca 2ϩ -permeable cation channels (ASICs) (Xiong et al., 2004) . Amiloride (100 M) or its derivative, bepridil (50 M), had no significant effect on END (Fig.  3A) , they failed to block Ca 2ϩ influx (data not shown), and they did not prevent cell death after glutamate excitotoxicity (Fig. 3C) . Furthermore, the activation of ASICs was unlikely because our perfusion conditions prevented the development of acidic conditions, demonstrating that ASICs are not responsible for mediating I EIC .
Excitotoxic injury with NMDA can also induce a postexposure current (I pe ) that was shown to be not selective for Ca 2ϩ (P Ca :P Na ϭ 7:1) and not altered by removal of [Ca 2ϩ ] e in acutely isolated hippocampal neurons (Chen et al., 1997) . In contrast, steady-state I EIC has a high Ca 2ϩ selectivity (P Ca : P Na ϭ 50:1), and it is abolished upon omission of [Ca 2ϩ ] e , demonstrating that I pe is not responsible for mediating I EIC .
Taken together, these results demonstrate that TRPM-7, ASIC, or I pe are not significantly contributing to the initial Ca 2ϩ entry or END during the first hour of the postglutamate treatment paradigm and that I EIC is a unique Ca 2ϩ current that is mediated by a novel Ca 2ϩ -permeable channel.
Discussion
This study demonstrates that glutamate excitotoxicity activates a previously undetected Ca 2ϩ -permeable channel in cultured hippocampal neurons that carries the injury-induced current (I EIC ), primarily responsible for the initial sustained increases in [Ca 2ϩ ] i following neuronal injury that maintains END and ultimately leads to neuronal death. Inhibiting this I EIC -Ca 2ϩ -permeable channel within the window of opportunity after glutamate excitotoxicity reversed END, blocked Ca 2ϩ entry, and prevented delayed neuronal death. To our knowledge, the development of the Ca 2ϩ entry inhibitor-resistant I EIC -Ca 2ϩ -permeable channel following glutamate excitotoxicity provides the first molecular insight into the Ca 2ϩ paradox, and it explains why many of the clinical trials using conventional strategies to inhibit Ca 2ϩ entry have not been effective in treating excitotoxic neuronal injury and stroke (Ikonomidou and Turski, 2002; Wahlgren and Ahmed, 2004) .
Numerous studies have demonstrated a causal relationship between ischemia induced neuronal death and [Ca 2ϩ ] i accumulation (Kristiá n and Siesjö, 1998 (Limbrick et al., 2003) , since the presence of the NMDA channel inhibitor MK-801 during glutamate injury prevents cell death and END. In contrast, MK-801 administered after excitotoxic injury did not prevent cell death, inhibit Ca 2ϩ entry during END, or inhibit the I EIC -Ca 2ϩ -permeable channel. In addition, depolarization induced Ca 2ϩ entry alone did not produce END (Coulter et al., 1992) . Treatments with high concentrations of potassium chloride or substitution of [Ca 2ϩ ] e with [Ba 2ϩ ] e during glutamate excitotoxicity both caused neuronal depolarization, but they did not cause the induction of END (Coulter et al., 1992) . These findings indicate that the I EICCa 2ϩ -permeable channel is activated by an NMDA/Ca 2ϩ mechanism. Since I EIC could be observed immediately following 10-min glutamate stimulation, it is unlikely that I EIC represents a newly synthesized channel, since this may be too rapid a time frame for de novo protein synthesis and insertion into the membrane. It is more likely that excitotoxic stimulation would trigger second messenger cascades, leading to post-translational modifications of existing membrane proteins or activation of a dormant channel to activate I EIC . Indeed, NMDA-dependent changes in protein phosphorylation Durkin et al., 1997) , protease activity such as the calpains (Minger et al., 1998; Simpkins et al., 2003) , and numerous other second messenger effects have been reported during glutamate excitotoxicity. Such alterations in key proteins or enzyme activities could result in the activation of the I EIC -Ca 2ϩ -permeable channel. Future studies are planned to investigate these possibilities and to elucidate the molecular basis of the activation of the I EIC -Ca 2ϩ -permeable channel using both in vitro and in vivo models of stroke and brain injury.
Protracted Ca 2ϩ increases upon excitotoxicity persist well beyond the period of glutamatergic injury (Dubinsky, 1993; Limbrick et al., 1995) and cause diverse pathophysiological changes, including generation of free radicals, neuronal acidity, activation of proteases all of which can trigger neurodegenerative processes (Lipton, 1999) . These sustained elevations in [Ca 2ϩ ] i represent a prolonged imbalance in Ca 2ϩ homeostasis, and they correlate with subsequent excitotoxic neuronal death (Dubinsky, 1993; Limbrick et al., 1995) . This [Ca 2ϩ ] i deregulation could result either from a persistent influx of [Ca 2ϩ ] e and/or from sustained impairment of neuronal Ca 2ϩ sequestration/extrusion mechanisms. Indeed, recent discoveries that TRPM-7 (Aarts et al., 2003) and ASICs (Xiong et al., 2004) allow for Ca 2ϩ entry upon hypoxia-ischemia and that the plasma membrane Na ϩ /Ca 2ϩ exchanger undergoes cleavage upon excitotoxicity (Bano et al., 2005) suggests that both these possibilities exist. These observations demonstrate the importance of elucidating the mechanisms underlying the sustained [Ca 2ϩ ] i elevations following glutamate excitotoxicity.
Earlier attempts to elucidate the basis of the postexcitotoxic injury-induced Ca 2ϩ paradox indicated that an influx of extracellular Ca 2ϩ was responsible for END (Limbrick et al., 2003) . However that study did not identify the source or nature of this postinjury Ca 2ϩ entry. The data presented here are a major advance over this earlier work, and they demonstrate that a unique Ca 2ϩ current is activated upon excitotoxic injury that is the molecular basis for the influx of extracellular Ca 2ϩ responsible for END. This study not only documents the existence of this novel Ca 2ϩ -permeable channel but also provides a careful pharmacological characterization of the channel and differentiates it from other types of calcium channels reported in the literature. Our findings demonstrate that the I EIC -Ca 2ϩ -permeable channel is acti-
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vated by glutamate excitotoxicity and blocking its activity after the excitotoxic insult prevents [Ca 2ϩ ] i accumulation and neuronal cell death. These findings suggest that activation of I EIC -Ca 2ϩ -permeable channel could represent an early step in the genesis of the injury induced [Ca 2ϩ ] i plateau. The possible identification of a novel molecular target compliant to pharmacological manipulations opens exciting avenues for the treatment of acute and chronic neurological disorders associated with glutamate excitotoxicity. Elucidation of the I EIC may provide a new target for a significant extension of the therapeutic window to prevent neuronal death in stroke and offer new hope in the search for novel agents to treat stroke and excitotoxic brain injury.
